Beijing Foyou Pharma(601089.SH): Ethylicosapentaenoic Acid Soft Capsules Obtained Drug Registration Certificate.

Beijing Foyou Pharma (601089.SH) announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhejiang Aisheng") has recently received the Drug Registration Certificate (Certificate No.: 2026S00777) for Twenty Carbon Five Ethyl Ester Soft Capsules (specification: 1.0g) issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), approving the production of the drug. According to data from Mineweb, in 2025, the sales of Twenty Carbon Five Ethyl Ester Soft Capsules in China's three major terminal markets and six major markets are approximately 43,570,000 yuan, with sales of 4,270,000 yuan in urban public hospitals and county-level public hospitals, 30,000 yuan in urban community centers and township health centers, and 39,270,000 yuan in urban physical pharmacies and online pharmacies.